Tags

Type your tag names separated by a space and hit enter

Peritoneal dialysis is not a superior therapy to hemodialysis: a comparison.
Blood Purif. 2012; 33(1-3):160-4.BP

Abstract

After initial reports suggesting that patients initiating peritoneal dialysis (PD) had better survival than patients on conventional dialysis in the first year, many investigators have scrutinized the existing databases to determine the reasons for this apparent difference. It is clear that patients starting on PD are selected - they are younger and have less comorbidity compared to the general population on dialysis. Despite improvements in the morbidities of patients on PD over the past 15 years, the survival of patients on hemodialysis over 5 years is greater than for patients on hemodialysis. The latest analysis points to the considerable survival difference in patients who start dialysis with an arteriovenous fistula or graft compared to patients who start dialysis with a cuffed catheter. Thus, the apparent early survival advantage for patients starting PD can be attributed to selection and comorbidities. Data are emerging that the best survival occurs when patients are dialyzed more frequently than the conventional three times a week. The questions regarding dialysis modality now can shift from whether to encourage PD to how to encourage frequent hemodialysis.

Authors+Show Affiliations

Department of Internal Medicine, University of Iowa Carver College of Medicine and the VA Medical Center, Iowa City, IA 52242, USA. john-stokes@uiowa.edu

Pub Type(s)

Comparative Study
Journal Article

Language

eng

PubMed ID

22269603

Citation

Stokes, John B.. "Peritoneal Dialysis Is Not a Superior Therapy to Hemodialysis: a Comparison." Blood Purification, vol. 33, no. 1-3, 2012, pp. 160-4.
Stokes JB. Peritoneal dialysis is not a superior therapy to hemodialysis: a comparison. Blood Purif. 2012;33(1-3):160-4.
Stokes, J. B. (2012). Peritoneal dialysis is not a superior therapy to hemodialysis: a comparison. Blood Purification, 33(1-3), 160-4. https://doi.org/10.1159/000334159
Stokes JB. Peritoneal Dialysis Is Not a Superior Therapy to Hemodialysis: a Comparison. Blood Purif. 2012;33(1-3):160-4. PubMed PMID: 22269603.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Peritoneal dialysis is not a superior therapy to hemodialysis: a comparison. A1 - Stokes,John B, Y1 - 2012/01/20/ PY - 2012/1/25/entrez PY - 2012/1/25/pubmed PY - 2012/8/8/medline SP - 160 EP - 4 JF - Blood purification JO - Blood Purif. VL - 33 IS - 1-3 N2 - After initial reports suggesting that patients initiating peritoneal dialysis (PD) had better survival than patients on conventional dialysis in the first year, many investigators have scrutinized the existing databases to determine the reasons for this apparent difference. It is clear that patients starting on PD are selected - they are younger and have less comorbidity compared to the general population on dialysis. Despite improvements in the morbidities of patients on PD over the past 15 years, the survival of patients on hemodialysis over 5 years is greater than for patients on hemodialysis. The latest analysis points to the considerable survival difference in patients who start dialysis with an arteriovenous fistula or graft compared to patients who start dialysis with a cuffed catheter. Thus, the apparent early survival advantage for patients starting PD can be attributed to selection and comorbidities. Data are emerging that the best survival occurs when patients are dialyzed more frequently than the conventional three times a week. The questions regarding dialysis modality now can shift from whether to encourage PD to how to encourage frequent hemodialysis. SN - 1421-9735 UR - https://www.unboundmedicine.com/medline/citation/22269603/Peritoneal_dialysis_is_not_a_superior_therapy_to_hemodialysis:_a_comparison_ L2 - https://www.karger.com?DOI=10.1159/000334159 DB - PRIME DP - Unbound Medicine ER -